𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pramipexole for stage 2 treatment-resistant major depression: An open study

✍ Scribed by Takeshi Inoue; Yuji Kitaichi; Takuya Masui; Shin Nakagawa; Shuken Boku; Teruaki Tanaka; Katsuji Suzuki; Yasuya Nakato; Reiko Usui; Tsukasa Koyama

Book ID
116841992
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
238 KB
Volume
34
Category
Article
ISSN
0278-5846

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Olanzapine augmentation of milnacipran f
Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression: an open study
✍ Shuken Boku; Takeshi Inoue; Hiroshi Honma; Shigehiro Matsubara; Shin Nakagawa; T πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 88 KB

## Objective Olanzapine augmentation of fluoxetine, a selective serotonin reuptake inhibitor, is an effective augmentation therapy for treatment‐resistant depression (TRD). However, studies of olanzapine augmentation of other antidepressants are few. We investigated the efficacy and safety of olanz